AbbVie Inc. revenue for the last year amounted to 54.32 B USD, the most of which — 26.14 B USD — came from its highest performing source at the moment, Immunology, the year earlier bringing 28.92 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought AbbVie Inc. 41.88 B USD, and the year before that — 45.71 B USD.